1. A Protective Monoclonal Antibody Targets a Site of Vulnerability on the Surface of Rift Valley Fever Virus
- Author
-
Allen, ER, Krumm, SA, Raghwani, J, Halldorsson, S, Elliott, A, Graham, VA, Koudriakova, E, Harlos, K, Wright, D, Warimwe, GM, Brennan, B, Huiskonen, JT, Dowall, SD, Elliott, RM, Pybus, OG, Burton, DR, Hewson, R, Doores, KJ, and Bowden, TA
- Subjects
viruses ,bunyavirus ,Antibodies, Viral ,Models, Biological ,Article ,immune response ,Protein Domains ,Viral Envelope Proteins ,Neutralization Tests ,antibody ,vaccine ,Chlorocebus aethiops ,Animals ,Humans ,phlebovirus ,structure ,Amino Acid Sequence ,Vero Cells ,lcsh:QH301-705.5 ,virus-host interactions ,Glycoproteins ,Mice, Inbred BALB C ,Antibodies, Monoclonal ,neutralization ,Rift Valley fever virus ,antiviral ,Antibodies, Neutralizing ,Recombinant Proteins ,HEK293 Cells ,lcsh:Biology (General) ,Immunoglobulin G ,Female ,Immunization ,Rabbits - Abstract
Summary The Gn subcomponent of the Gn-Gc assembly that envelopes the human and animal pathogen, Rift Valley fever virus (RVFV), is a primary target of the neutralizing antibody response. To better understand the molecular basis for immune recognition, we raised a class of neutralizing monoclonal antibodies (nAbs) against RVFV Gn, which exhibited protective efficacy in a mouse infection model. Structural characterization revealed that these nAbs were directed to the membrane-distal domain of RVFV Gn and likely prevented virus entry into a host cell by blocking fusogenic rearrangements of the Gn-Gc lattice. Genome sequence analysis confirmed that this region of the RVFV Gn-Gc assembly was under selective pressure and constituted a site of vulnerability on the virion surface. These data provide a blueprint for the rational design of immunotherapeutics and vaccines capable of preventing RVFV infection and a model for understanding Ab-mediated neutralization of bunyaviruses more generally., Graphical Abstract, Highlights • The Gn glycoprotein of Rift Valley fever virus elicits potent neutralizing antibodies • Derived a class of monoclonal antibodies that protects in an animal model • A distinct region on RVFV Gn constitutes a key site of vulnerability • Antibodies are predicted to prevent exposure of viral fusion loops, Allen et al. reveal a molecular basis of antibody-mediated neutralization of Rift Valley fever virus, an important human and animal pathogen. They isolate and demonstrate the protective efficacy of a monoclonal antibody in a murine model of virus infection, providing a blueprint for rational therapeutic and vaccine design.
- Published
- 2018